Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE(®)) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical Trial
基于 EMPEROR-Preserved 临床试验,评估恩格列净 (JARDIANCE®) 在法国治疗射血分数保留型心力衰竭患者的公共卫生影响和成本效益
期刊:Pharmacoeconomics-Open
影响因子:2.1
doi:10.1007/s41669-023-00432-z
Fauchier, Laurent; Lamblin, Nicolas; Tardu, Jean; Bellier, Lucile; Groyer, Harinala; Ittah, Deborah; Chollet, Julien; Linden, Stephan; Levy, Pierre